Last reviewed · How we verify

NCT03618875

Reduction of Post Intravitreal Injection Bleeding and Pain by Ice

Completed NA Last updated 7 August 2018
What this trial tests

NA trial testing ice pack in Pain in 40 participants. Completed in 25 November 2017.

Timeline
1 January 2017
Primary endpoint
1 November 2017
25 November 2017

Quick facts

Lead sponsorWolfson Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 January 2017
Primary completion1 November 2017
Estimated completion25 November 2017
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Wolfson Medical Center

Who can join

18 and older, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Intravitreal injections are an efficient method for delivering intraocular therapeutic agents in numerous ophthalmologic diseases. However, side effects, such as pain and subconjunctival hemorrhage remain a major concern. Prevention or alleviation of those side effects might shorten the healing duration and improve patients' quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ice pack

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Wolfson Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03618875.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing